注射用益气复脉治疗分水岭脑梗死的效果分析  

Curative effects of Yiqifumai injection on acute cerebral watershed infarction

作　　者：翟飞鹏[1] 孙雅轩[1] 刘毅[1] 董银桃[1] 胡风云[1] 

机构地区：[1]山西省人民医院神经内科,太原030012

出　　处：《中国医药》2014年第8期1146-1148,共3页China Medicine

摘　　要：目的 观察注射用益气复脉治疗急性分水岭脑梗死的临床效果.方法 80例急性分水岭脑梗死患者完全随机分为观察组（40例）,对照组（40例）.2组均给予抗血小板聚集、调脂、调控血压、改善微循环及保护脑细胞等治疗,观察组在此基础上加用注射用益气复脉,5.2 g/d静脉滴注,共10 d.治疗前后应用美国国立卫生研究院卒中量表（NIHSS）进行神经功能缺损评分.结果 2组患者治疗后NIHSS评分均低于本组治疗前[观察组（8.4±2.5）分比（13.2±2.3）分,对照组（9.6±3.2）分比（13.4±2.7）分],观察组治疗后NIHSS评分明显低于对照组（P＜0.05）.观察组治疗有效率为85.0％（34/40）,明显高于对照组的65.0％ （26/40）（P＜0.05）.2组均无明显不良反应.结论 注射用益气复脉治疗分水岭脑梗死安全、有效.Objective To evaluate the efficacy of Yiqifumai injection on cerebral watershed infarction.Methods Eighty patients with cerebral infarction were randomly divided into observation group （n =40） and control group （n =40）.Two groups received anti-platelet aggregation,lipid and blood pressure regulation to improve microcirculation.Neurological deficit was assessed by the national institute of health stroke scale （NIHSS） before and after treatment.Results After treatment,NIHSS sores were lower than those before treatment in both groups [observation group （8.4 ± 2.5） scores vs （13.2 ± 2.3） scores,control group （9.6 ± 3.2） scores vs （13.4 ± 2.7） scores] ; NIHSS score in the observation group was significantly lower than that in the control group（P 〈 0.05）.The efficacy in the observation group was superior to that in the control group [85.0% （34/40） vs 65.0% （26/ 40）] （P 〈 0.05）.There were no obvious adverse reactions in two groups.There were no obvious adverse effects in two groups.Conclusion Yiqifumai injection is safe and effective for treating cerebral watershed infarction.

关 键 词：分水岭脑梗死 注射用益气复脉 美国国立卫生研究院卒中量表 

分 类 号：R741[医药卫生—神经病学与精神病学]